North America Kidney Function Tests Market to Grow with a CAGR of 9.92% through 2028
Rising Incidence of Diabetes and Hypertension
and increase in the aging population is expected to drive the North America Kidney
Function Tests Market growth in the forecast period, 2024-2028.
According to TechSci Research report, “North
America Kidney Function Tests Market – Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2028”, the North
America Kidney Function Tests Market stood at USD 351.52 billion in 2022 and is
anticipated to grow with a CAGR of 9.92% in the forecast period, 2024-2028. The
awareness among individuals regarding Kidney Function Tests has led to
favorable market conditions for the North America Kidney Function Tests market.
Several factors contribute to the growth of various Kidney Function Tests
products.
The increasing incidence of kidney disorders
and diseases is a substantial North America health challenge, and North America
is no exception. Kidney disorders encompass a spectrum of conditions that
impact the structure and function of the kidneys. One prominent factor
contributing to the growing prevalence of kidney disorders in North America is
the aging population. As individuals grow older, their kidneys naturally
experience structural and functional alterations. These age-related
transformations can result in a reduced capacity to effectively filter waste
products from the bloodstream, thereby elevating the susceptibility to
kidney-related complications.
Technological progress has played a pivotal
role in propelling the growth of the North America Kidney Function Tests
Market. These advancements have brought about a significant transformation in
the realm of kidney function testing, rendering it more precise, efficient, and
accessible. Among the most noteworthy technological breakthroughs in kidney
function testing is the introduction of automated chemistry analyzers. These
advanced machines facilitate the high-throughput examination of blood and urine
samples, providing swift and accurate results. Automation not only diminishes
the scope for human errors but also augments the efficiency of the testing
procedures, empowering healthcare providers to manage a larger volume of tests,
thereby enhancing the quality of patient care, which will further fuel market
growth.
On July 25, 2023, Baxter announced that it
would be spinning off its Renal Care and Acute Therapies North America business
units into an independent, publicly traded company. The new company, which will
be called Vantive, is expected to be launched in the next 12-18 months. Vantive
will focus on developing and commercializing products and services for kidney
care and other vital organ support.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "North America Kidney Function Tests Market”
The integration of telehealth and remote
monitoring technologies has made it easier for patients to access kidney
function testing and consult healthcare professionals. Patients can now
participate in virtual consultations, share test results electronically, and
receive real-time guidance on managing their kidney health. This technology has
improved patient engagement and healthcare accessibility.
In the contemporary fast-paced healthcare
environment, there is a critical need for rapid and precise diagnostic tools.
Kidney function tests fulfill this need by offering immediate insights into
renal health, enabling swift diagnoses. This becomes especially vital in
emergency situations, where timely decisions can be life-saving. Many
individuals in today's fast-paced world contend with chronic conditions such as
diabetes and hypertension, both of which pose risks to kidney health. Regular
kidney function tests serve as a vigilant monitoring tool, facilitating the
early detection of kidney-related complications and allowing for timely interventions.
The modern, hectic lifestyle often fosters unhealthy habits such as poor
dietary choices and a lack of physical activity, increasing the susceptibility
to kidney diseases. Kidney function tests are integral components of proactive
healthcare. They encourage individuals to take a proactive stance in assessing
their kidney health and implementing necessary lifestyle adjustments before
conditions escalate. Furthermore, kidney function tests can be conducted
remotely, enabling patients to engage in telemedicine consultations—a
particularly valuable option in today's fast-paced world, where time
constraints frequently limit in-person visits. Patients can readily share their
test results with healthcare providers and receive guidance on managing their
kidney health from the convenience of their homes.
Kidney function tests assist in the efficient
allocation of healthcare resources. By identifying individuals at high risk of
kidney diseases, healthcare providers can allocate resources and interventions
where they are needed most.
In recent times, Kidney function tests enable
the early detection of kidney disorders, even before symptoms manifest. In
recent times, early diagnosis is crucial for timely intervention and effective
management of kidney diseases. With the rising prevalence of chronic conditions
like diabetes and hypertension, kidney function tests play a vital role in
monitoring these conditions' impact on kidney health. Regular testing allows
healthcare providers to adjust treatment plans as needed. Recent advances in
healthcare emphasize personalized or precision medicine. Kidney function tests
provide individualized data, helping healthcare professionals tailor treatment
strategies to specific patient needs, improving treatment outcomes. In an era
of telehealth and remote patient monitoring, kidney function tests can be
conducted remotely, allowing patients to share results with healthcare
providers. This convenience is especially valuable in recent times when
in-person visits may be limited. However, the Evolving Healthcare Policies may
hinder market growth. Moreover, challenges related to Quality Assurance
Standards and Limited Access to Healthcare may pose obstacles to the Kidney
Function Tests market in the near future.
The North America Kidney Function Tests Market
is segmented into type, component, end-user, country distribution, and company.
Based on its type, the Urine tests offer a
wealth of information about kidney function from a single sample. This single
sample can provide data on various aspects of kidney health. GFR is a critical
indicator of kidney function. Urine tests can estimate GFR by measuring
substances like creatinine and albumin in the urine. Elevated protein levels in
urine (proteinuria) can indicate kidney damage or dysfunction. The presence of
blood cells in urine (hematuria) can signal various kidney disorders, including
infections, stones, or inflammation. Urine tests can assess the levels of
electrolytes like sodium, potassium, and calcium, providing insights into
kidney regulation of electrolyte balance. The pH of urine can indicate the
kidney's ability to regulate acid-base balance in the body.
Based on region, North America segment is
expected to grow during the forecast period. The United States
boasts a vast and advanced healthcare infrastructure, including numerous
hospitals, clinics, and diagnostic laboratories. These facilities are
well-equipped to conduct a wide range of kidney function tests, contributing to
the dominance of the market. The United States has a relatively high prevalence
of kidney diseases and related conditions, such as diabetes, hypertension, and
obesity. This high disease burden necessitates frequent kidney function
testing, leading to a robust market for these diagnostic services. The United
States is at the forefront of healthcare research and innovation. Research
institutions and healthcare facilities in the country actively participate in
clinical trials and research studies related to kidney diseases. This research
focus further fuels the demand for kidney function tests. The U.S. healthcare
system has widespread access to cutting-edge diagnostic technologies and
equipment, facilitating the accurate and efficient performance of kidney
function tests. Health insurance coverage in the United States often includes
reimbursement for kidney function tests, making these tests accessible to a
significant portion of the population.
The Canada market is poised to be the
fastest-growing market, offering lucrative growth opportunities for Kidney
Function Tests players during the forecast period. Factors such as The elderly
are at a higher risk of kidney-related conditions, including Chronic Kidney
Disease (CKD). This demographic trend is expected to drive the demand for
kidney function tests. The prevalence of chronic diseases like diabetes and
hypertension is on the rise in Canada. These conditions are major risk factors
for kidney diseases, increasing the need for regular kidney function monitoring
through tests.
Canada's publicly funded healthcare system
places a strong emphasis on preventive healthcare and early disease detection.
As a result, the government and healthcare authorities actively promote regular
health screenings, including kidney function tests, to detect and manage kidney
disorders early. The adoption of telehealth services in Canada has made it
easier for individuals to access healthcare professionals and diagnostic
services, including kidney function tests. Telehealth has expanded the reach of
healthcare services to underserved and remote areas, contributing to market
growth. Public awareness campaigns about kidney health and the importance of
regular screenings are gaining momentum in Canada.
Major
companies operating in North America Kidney Function Tests Market
are:
- Baxter
International Inc.
- Abbott
Laboratories, Inc.
- F. Hoffmann-La
Roche Ltd
- Nova Biomedical
Corporation
- Laboratory
Corporation of America Holdings
- Siemens
Healthineers
- Fresenius SE
& Co. KGaA
-
Cook Group
Download Free Sample Report
Customers can also request for 10% free
customization on this report
“The advancement in technology and increasing prevalence
of kidney disorder are key drivers of the Kidney Function Tests market. In
recent years, Growing awareness of kidney health and preventive healthcare
measures encourages individuals to undergo regular kidney function tests,
contributing to market expansion. Moreover, the growing consumer emphasis on
preventative healthcare products has enhanced production and marketing efforts.
To meet the demands of the market, manufacturers are increasingly incorporating
cutting-edge technologies with high production efficiency. Rising consumer
acceptance and continuous product innovation will further ensure the growth of
the Kidney Function Tests and supplements market in the coming years.,” said
Mr. Karan Chechi, Research Director with TechSci Research, a research-based
management consulting firm.
“North America Kidney Function Tests Market Segmented By Type (Urine
Test, Blood Test), By Component (Dipsticks, Reagents, Kits & Assays,
Others), By End-User (Hospitals & Clinics, Diagnostic Laboratories,
Others), By Country, Competition, Forecast, & Opportunities 2018-2028”, has evaluated the future growth
potential of North America Kidney Function Tests Market and provides statistics
& information on market size, structure and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in North America Kidney Function Tests Market.
Contact
TechSci Research LLC
420 Lexington Avenue,
Suite 300, New York,
United States- 10170
M: +13322586602
Email: [email protected]
Website: https://www.techsciresearch.com